CDK5RAP2 Antikörper (N-Term)

Produktnummer ABIN7188618

Produktdetails anti-CDK5RAP2 Antikörper

Target: CDK5RAP2 (CDK5 Regulatory Subunit Associated Protein 2 (CDK5RAP2))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDK5RAP2 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from the N-terminal region of Human CDK5 Activator-binding C48.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC:1:100-1:300, ELISA:1:20000,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu CDK5RAP2

Target: CDK5RAP2 (CDK5 Regulatory Subunit Associated Protein 2 (CDK5RAP2))

Andere Bezeichnung: CDK5RAP2 (CDK5RAP2 Produkte)

Synonyme: EGFL5 antikoerper, C48 antikoerper, Cep215 antikoerper, MCPH3 antikoerper, 2900018K03Rik antikoerper, an antikoerper, mKIAA1633 antikoerper, CDK5 regulatory subunit associated protein 2 antikoerper, CDK5 regulatory subunit-associated protein 2 antikoerper, CDK5RAP2 antikoerper, LOC100156240 antikoerper, cdk5rap2 antikoerper, Cdk5rap2 antikoerper

Hintergrund: C48 antibody, CDK5 activator-binding protein C48 antibody, CDK5 regulatory subunit associated protein 2 antibody, CDK5 regulatory subunit-associated protein 2 antibody, CDK5RAP2 antibody, centrosomal protein 215 kDa antibody, Centrosome-associated protein 215 antibody, CEP215 antibody, CK5P2_HUMAN antibody, MCPH3 antibody

UniProt: Q96SN8

Pathways: M Phase, SARS-CoV-2 Protein Interaktom